Christine Marie Utter, SVP, CHIEF ACCOUNTING OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 19,686 shares at $75.56 ($1.5M) on 2026-06-17, disclosed to the SEC on 2026-06-22.
Scheduled sale ($1.5M) by SVP, CHIEF ACCOUNTING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PTCT | SELL | 2026-01-08 | $202K | — | Filing → |
| PTCT | SELL | 2025-02-21 | $88K | — | Filing → |
| PTCT | SELL | 2025-01-10 | $191K | — | Filing → |